Multicenter, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Fluconazole in Hypercalcicuric Patients With Increased 1.25(OH) 2D Levels

NCT04495608 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

56

Enrollment

OTHER

Sponsor class

Conditions

Nephrolithiasis
Nephrocalcinosis
Hypercalciuria

Interventions

DRUG: Fluconazole
DRUG: Placebo

Sponsor

Hospices Civils de Lyon